edited by Jeffrey A. Cohen, MD, and Richard A. Rudick, MD, 928 pp, $299.95, ISBN-10: 1-84184-525-6, London, England, Informa Healthcare, 2007.
The field of multiple sclerosis (MS) therapeutics is burgeoning. This means that it is very difficult to find one's way through the jungle of the ever-increasing number of potentially promising treatments. The book Multiple Sclerosis Therapeutics, edited by Jeffrey A. Cohen, MD, and Richard A. Rudick, MD, now in its third edition, is an excellent guide for orientation not only for MS experts, but also for neuroimmunologists and neurologists in general.
Hohlfeld R. Multiple Sclerosis Therapeutics, 3rd ed. Arch Neurol. 2007;64(11):1670-1671. doi:10.1001/archneur.64.11.1670-b